מרונם 500 מג

Nazione: Israele

Lingua: ebraico

Fonte: Ministry of Health

Principio attivo:

MEROPENEM AS TRIHYDRATE

Commercializzato da:

PFIZER PFE PHARMACEUTICALS ISRAEL LTD

Codice ATC:

J01DH02

Forma farmaceutica:

אבקה להכנת תמיסה לזריקה

Composizione:

MEROPENEM AS TRIHYDRATE 500 MG/VIAL

Via di somministrazione:

תוך-ורידי

Tipo di ricetta:

מרשם נדרש

Prodotto da:

ASTRA ZENECA UK LIMITED

Gruppo terapeutico:

MEROPENEM

Area terapeutica:

MEROPENEM

Indicazioni terapeutiche:

Meronem is indicated for treatment in adults and children of the following severe infections caused by single or multiple susceptible bacteria sensitive to meropenem: - Pneumonias and nosocomial pneumonias. - Pulmonary infections in patients with cystic fibrosis. - Urinary tract infections. - Intra-abdominal infections. - Gynecological infections such as endometritis and pelvic inflammatory disease. - Skin and skin structure infections. - Meningitis. - Septicemia. Meronem has proved efficacious alone or in combination with other antimicrobial agents in the treatment of polymicrobial infections. There is no experience in pediatric patients with neutropenia or primary or secondary immunodeficiency.

Data dell'autorizzazione:

2012-01-31